FDA warning letter
Issue date
18 Jul 2022
Issuing office
Division of Pharmaceutical Quality Operations III
Posted date
26 Jul 2022
Subject
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
Products & Services
Drugs
Jost Chemical
Manufacturer
Warning letter
Headquarters
United States of AmericaSites
United States of America